Navigation Links
MedQuist Announces Entry of Final Judgment Approving Settlement and Dismissing Medical Transcriptionist Class Action

MOUNT LAUREL, N.J., April 2 /PRNewswire-FirstCall/ -- MedQuist Inc. (Nasdaq: MEDQ), a leading provider of medical transcription services, is pleased to announce entry of final judgment approving settlement and dismissing the consolidated medical transcriptionist class action commenced against the Company following disclosure of the results of the internal review of its historic billing practices in July 2004. MedQuist cares deeply about its workforce, and throughout this litigation the Company maintained that it has always correctly paid its medical transcriptionists, that it did nothing wrong, and that the allegations in the suit were completely meritless. The Court's action this week vindicates the Company's position: "[N]otwithstanding Plaintiffs' expansive discovery and investigative work, no evidence emerged to support their allegations that MedQuist had systematically underpaid its transcriptionists." The full text of the Court's Final Judgment and Opinion are available through the Company's Web site at

As originally reported by MedQuist in December 2004 and October 2005, certain individual medical transcriptionists commenced class action litigation against the Company alleging that MedQuist systematically and wrongfully underpaid medical transcriptionists. After it became clear that Plaintiffs could not prove the claims alleged against MedQuist, the parties reached a settlement, whereby MedQuist agreed to an injunction requiring it to implement certain measures to ensure transparency in medical transcription pay. MedQuist hopes that as a recognized leader in the medical transcription field, its agreement to increase transparency will pave the way for similar measures throughout the industry.

As part of the settlement, the Company also agreed to pay $1.5 million, approximately $1.1 million of which will be given to the Association for Healthcare Documentation Integrity (AHDI) to fund programs for the general benefit of medical transcriptionists and the medical transcription industry. The balance of the settlement funds will be paid to cover settlement administration costs and Plaintiffs' counsel's out-of-pocket expenses. Because there was no evidence to support Plaintiffs' allegations that transcriptionists were systematically underpaid, the settlement approved by the Court does not include any payment to the named Plaintiffs or the settlement class members, nor does the settlement include any payment for Plaintiffs' attorneys' fees. However, as part of the settlement, AHDI agreed to offer certain programs free of charge to class members as outlined in the settlement documentation. Additional information about these benefits is available through the settlement administrator at and/or AHDI at

Resolution of this litigation follows the Company's resolution of the previously disclosed Department of Justice and Securities and Exchange Commission investigations, the previously disclosed settlements reached in the South Broward customer class action and the Steiner shareholder class action, and dismissal with prejudice of the Kanter shareholder derivative class action. The Company has now resolved all class action litigation and governmental investigation matters arising from the internal review of its historic billing practices.

About MedQuist:

MedQuist is a leading provider of medical transcription services, and a leader in technology-enabled clinical documentation workflow. MedQuist's enterprise solutions -- including mobile voice capture devices, speech recognition, Web-based workflow platforms, and global network of medical editors -- help healthcare facilities improve patient care, increase physician satisfaction, and lower operational costs. For more information, please visit

"Safe Harbor" Statement under the U.S. Private Securities Litigation Reform Act of 1995: Statements in this press release regarding MedQuist's business that are not historical facts are "forward-looking statements" that involve risks and uncertainties. Actual outcomes and results may differ materially from what is expressed or forecasted in forward-looking statements. As a result, forward-looking statements speak only as of the date they were made, and the Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

SOURCE MedQuist Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. MedQuist Announces Resolution of SEC Investigation
2. MedQuist Reports Fourth Quarter and Year End 2008 Results
3. MedQuist Announces Resolution of the DOJ Investigation and Dismissal of Shareholder Lawsuits
4. New Jersey-Based MedQuist Pays U.S. $6.6 Million to Resolve False Claims Act Allegations
5. MedQuist and Primordial to Demonstrate Integrated Applications at RSNA
6. MedQuist and Clario Form Partnership to Integrate zVision Radiology Practice Management Software with SpeechQ for Radiology
7. MedQuist Introduces SpeechQ for Radiology Integrated with RadWorkFlow
8. MedQuist Reports Third Quarter 2008 Results
9. MedQuist Reports Second Quarter 2008 Results
10. MedQuist Announces Changes to Board of Directors
11. MedQuist Announces Declaration of $2.75 per share Dividend on Common Stock
Post Your Comments:
(Date:10/13/2017)... ... October 13, 2017 , ... ProVest Insurance ... greater Dallas, Miami, and Raleigh regions, is organizing an extended charity drive to ... and deadly chromosome abnormality. , After struggling since birth with several health challenges, ...
(Date:10/13/2017)... ... October 13, 2017 , ... While it’s often important to take ... an inventor from Austin, Texas, has identified a solution. , She developed a prototype ... restricted lighting. As such, it eliminates the need to turn on a light when ...
(Date:10/13/2017)... ... October 13, 2017 , ... PurhealthRX , a leading ... Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil will revolutionize the rapidly ... CBD form that can be easily incorporated into liquid products, while reducing costs to ...
(Date:10/13/2017)... ... October 13, 2017 , ... Apple Rehab Shelton Lakes ... a mock evacuation of the facility as part of a disaster drill on October ... Hose EMS and Shelton City Emergency Manager, as well as the Connecticut Long ...
(Date:10/13/2017)... New York, NY (PRWEB) , ... October 13, 2017 , ... ... most influential people in business to advocate for action towards gender equality at their ... 18,000 views from around the globe, and reached a social audience of over 3 ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)... -- Caris Life Sciences ® , a leading innovator in ... medicine, today announced that St. Jude Medical Center,s Crosson ... as its 17 th member. Through participation with ... Institute will help develop standards of care and best ... cancer treatment more precise and effective. ...
(Date:10/10/2017)... Oct. 10, 2017  NDS received FDA 510(k) clearance in May ... battery-powered display stand specifically designed for endoscopy environments. An innovative secondary ... a clinical solution to support the improvement of patient outcomes, procedural ... ... ...
(Date:10/5/2017)... Ill. , Oct. 5, 2017  In ... Association of Oral and Maxillofacial Surgeons (AAOMS) released ... opioids – to be used as a first-line ... pain. Recognizing ... the AAOMS White Paper "Opioid Prescribing: Acute and ...
Breaking Medicine Technology: